Taiwan's ScinoPharm forges link for biosimilars production with US firm

 
• By Ian Haydock

Taiwan's ScinoPharm is to make an investment in the US firm Tanvex Biologics, with the intention of building up joint capacity for the manufacture of biosimilars in the US market.

More from Focus On Asia

More from Scrip